Diagnosis and Management of MODY and Type 2 Diabetes

Diagnostic Approaches

The American Diabetes Association recommends genetic testing for diagnosing MODY, particularly in children and young adults without typical characteristics of Type 1 or Type 2 diabetes, and in patients with a family history of diabetes in successive generations 1, 2, 4
The American Diabetes Association suggests that Type 2 diabetes is diagnosed using standard criteria, such as fasting glucose, OGTT, or A1C, without genetic testing 3
Pancreatic autoantibody testing should be performed in children with overweight/obesity when Type 2 diabetes is suspected to exclude autoimmune Type 1 diabetes, as recommended by the American Diabetes Association 5, 6

MODY typically presents in young adults before age 25, with non-obesity and an autosomal dominant inheritance pattern, according to the American Diabetes Association 1, 2
Type 2 diabetes is characterized by increased BMI, features of metabolic syndrome, and absence of weight loss or ketoacidosis, as described by the American Diabetes Association 3
MODY patients have preserved pancreatic β-cell function and absence of pancreatic autoantibodies, whereas Type 2 diabetes patients typically have evidence of insulin resistance and variable C-peptide levels, as reported by the American Diabetes Association 2, 3

The American Diabetes Association recommends that GCK-MODY (MODY2) typically requires no pharmacological treatment due to stable, mild hyperglycemia 1, 2
HNF1A-MODY (MODY3) and HNF4A-MODY (MODY1) are treated with low-dose sulfonylureas as first-line treatment due to high sensitivity, as suggested by the American Diabetes Association 1, 2
Initial therapy for Type 2 diabetes includes lifestyle modification plus metformin in most cases, with a progressive approach with additional agents based on comorbidities and glycemic control, as recommended by the American Diabetes Association 3, 5, 6

Correct MODY diagnosis can lead to discontinuation of unnecessary insulin in some subtypes and appropriate use of sulfonylureas in HNF1A and HNF4A mutations, according to the American Diabetes Association 1, 2
MODY diagnosis has significant implications for family members due to autosomal dominant inheritance, and genetic counseling and testing of family members is recommended after MODY diagnosis, as suggested by the American Diabetes Association 1, 2, 4
Type 2 diabetes has complex polygenic inheritance with stronger environmental influences, as described by the American Diabetes Association 3